Living With Long COVID: LONGCOVID-EXPERIENCE

NCT06118112 | Completed

• 1 other identifier: LONGCOVID EXPERIENCE
• Study Type: observational
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence for at least two months, without being explained by an alternative diagnosis. The characteristics and clinical approach to persistent COVID syndrome are fairly well known, but not what the experience of people with persistent COVID is in relation to their daily life, their work life, and their experience with the healthcare received. Objective: to understand the experience of patients with persistent COVID in relation to the disease, the health care received and re-entry into the world of work Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.

Conditions

Long COVID; Experience, Life

Keywords

Post-Acute COVID-19 Syndrome; patient experience; qualitative research

Outcome Measures

Primary Outcomes (3)

• Experience of the disease

  How is living with LongCOVID. Assessed through semi-structured interviews.

  Up to three years

• Experience with healthcare received

  How is the experience of patients with the healthcare received for their condition. Assessed through semi-structured interviews.

  Up to three years

• Experience with return to work

  What were the barriers and facilitators for returning to work after the disease. Assessed through semi-structures interviews.

  Up to three years

Study Arms (1)

Persons with- long-covid

Women and men diagnosed with persistent COVID according to WHO (World HEalth Organization) criteria: persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients treated at the Parc Taulí Hospital Universitari, a hospital with a reference population of 400,000 urban people and 4,500 workers.

You may qualify if:

• women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis).
• treated at the Parc Taulí Hospital
• from 18 to 65 years

You may not qualify if:

• people who do not understand or can communicate in Catalan or Spanish.

Sponsors & Collaborators

• Corporacion Parc Tauli: lead
• Universitat Autonoma de Barcelona: collaborator

Study Sites (1)

Corporació Sanitària Parc Taulí

Sabadell, Barcelona, 08208, Spain

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Anna Selva, MD, MPH, PhD

  Parc Taulí, Hospital Universitari- I3PT

  PRINCIPAL INVESTIGATOR

• Juan Leiva, PhD

  Universitat Autònoma Barcelona

  STUDY DIRECTOR

• Pilar Peña, MD

  Parc Taulí, Hospital Universitari- I3PT

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Co-principal investigator

Study Record Dates

• First Submitted: September 15, 2023
• First Posted: November 7, 2023
• Study Start: September 18, 2023
• Primary Completion: June 30, 2024
• Study Completion: December 30, 2024
• Last Updated: April 13, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)